Ineart Cryogenics And Allied Gases Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 24-10-2024
- Paid Up Capital ₹ 2.50 M
as on 24-10-2024
- Company Age 21 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 18.08 Cr
as on 24-10-2024
- Revenue -26.53%
(FY 2023)
- Profit -48.81%
(FY 2023)
- Ebitda -45.20%
(FY 2023)
- Net Worth 26.10%
(FY 2023)
- Total Assets -10.16%
(FY 2023)
About Ineart Cryogenics And Allied Gases
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹18.08 Cr.
Anshu Jain and Palash Jain serve as directors at the Company.
- CIN/LLPIN
U11201MP2003PTC016048
- Company No.
016048
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Aug 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Dhar, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ineart Cryogenics And Allied Gases?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anshu Jain  | Director | 29-Aug-2003 | Current |
| Palash Jain | Director | 11-Jun-2019 | Current |
Financial Performance of Ineart Cryogenics And Allied Gases.
Ineart Cryogenics And Allied Gases Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 26.53% decrease. The company also saw a substantial fall in profitability, with a 48.81% decrease in profit. The company's net worth Soared by an impressive increase of 26.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ineart Cryogenics And Allied Gases?
In 2023, Ineart Cryogenics And Allied Gases had a promoter holding of 53.38% and a public holding of 46.62%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Shree Veer Prabhu Natural Products Private LimitedActive 2 years 11 months
Palash Jain is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Jul 2024 | ₹3.30 M | Open |
Hdfc Bank Limited Creation Date: 07 Jul 2024 | ₹4.70 M | Open |
Others Creation Date: 15 May 2024 | ₹4.00 M | Open |
How Many Employees Work at Ineart Cryogenics And Allied Gases?
Unlock and access historical data on people associated with Ineart Cryogenics And Allied Gases, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ineart Cryogenics And Allied Gases, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ineart Cryogenics And Allied Gases's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
